Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 3, 2013, Pages 219-233

  Byer, Stephanie J ^a   Brossier, Nicole M ^a,b   Peavler, Lafe T ^a   Eckert, Jenell M ^a   Watkins, Stacey ^a,b   Roth, Kevin A ^a   Carroll, Steven L ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ErbB membrane tyrosine kinases; Nerve sheath tumor; Neurofibromatosis type 1; Schwann cell; Tumor cell invasion

Indexed keywords

AMPHIREGULIN; BETACELLULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LIGAND; RECOMBINANT ERYTHROPOIETIN; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHWANN CELL;

ANIMALS; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIGANDS; NEOPLASM INVASIVENESS; NERVE SHEATH NEOPLASMS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCHWANN CELLS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84874661320     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182859939     Document Type: Article

References (31)

1. Evans DG, Baser ME, McGaughran J, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-14
2. McCaughan JA, Holloway SM, Davidson R, et al. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1. J Med Genet 2007;44: 463-66
3. Ferner RE, O'Doherty MJ. Neurofibroma and schwannoma. Curr Opin Neurol 2002;15:679-84
4. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002;62: 1573-77
5. Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: The Italian and German Soft Tissue Sarcoma Cooperative Group. J Clin Oncol 2005;23:8422-30
6. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986; 57:2006-21
7. Frohnert PW, Stonecypher MS, Carroll SL. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line. Glia 2003;43:104-18
8. DeClue JE, Heffelfinger S, Benvenuto G, et al. Epidermal growth factor receptor expression in neurofibromatosis type 1Yrelated tumors and NF1 animal models. J Clin Invest 2000;105:1233-41
9. Li H, Velasco-Miguel S, Vass WC, et al. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model. Cancer Res 2002;62:4507-13
10. Perry A, Kunz SN, Fuller CE, et al. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J Neuropathol Exp Neurol 2002;61:702-9
11. Holtkamp N, Malzer E, Zietsch J, et al. EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy. Neuro-Oncology 2008;10:946-57
12. Keizman D, Issakov J, Meller I, et al. Expression and significance of EGFR in malignant peripheral nerve sheath tumor. J Neurooncol 2009; 94:383-88
13. Wu J, Crimmins JT, Monk KR, et al. Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma. Am J Pathol 2006;168:1686-96
14. Ling BC, Wu J, Miller SJ, et al. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell 2005;7:65-75
15. Frohnert PW, Stonecypher MS, Carroll SL. Lysophosphatidic acid promotes the proliferation of adult Schwann cells isolated from axotomized sciatic nerve. J Neuropathol Exp Neurol 2003;62:520-29
16. Stonecypher MS, Byer SJ, Grizzle WE, et al. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene 2005;24:5589-605
17. Eckert JM, Byer SJ, Clodfelder-Miller BJ, et al. Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells. Glia 2009;57:1501-20
18. Byer SJ, Eckert JM, Brossier NM, et al. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptorYindependent manner. Neuro-Oncology 2011;13:28-41
19. Muir D. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metastasis 1995;13:303-14
20. Shin KJ, Wall EA, Zavzavadjian JR, et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA 2006;103: 13759-64
21. Stonecypher MS, Chaudhury AR, Byer SJ, et al. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J Neuropathol Exp Neurol 2006;65:162-75
22. Buccione R, Orth JD, McNiven MA. Foot and mouth: Podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004;5: 647-57
23. Ahmed Z, Brown RA. Adhesion, alignment, and migration of cultured Schwann cells on ultrathin fibronectin fibres. Cell Motil Cytoskeleton 1999;42:331-43
24. McCarthy JB, Palm SL, Furcht LT. Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J Cell Biol 1983;97:772-77
25. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 1997;14:67-116
26. Haraida S, Nerlich AG, Bise K, et al. Comparison of various basement membrane components in benign and malignant peripheral nerve tumours. Virchows Archiv A Pathol Anat Histopathol 1992;421:331-38
27. Lantini MS, Cossu M, Isola M, et al. Subcellular localization of epidermal growth factor receptor in human submandibular gland. J Anat 2006;208: 595-99
28. Moasser MM. The oncogene HER2: Its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007;26:6469-87
29. Wu J, Williams JP, Rizvi TA, et al. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehogYexpressing cells. Cancer Cell 2008;13:105-16
30. Zheng H, Chang L, Patel N, et al. Induction of abnormal proliferation by nonmyelinating Schwann cells triggers neurofibroma formation. Cancer Cell 2008;13:117-28
31. Le LQ, Liu C, Shipman T, et al. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. Cancer Res 2011; 71:4686-95